CVS HEALTH CORPORATION CVS Cash Flow

Cvs health corporation (CVS)

CashFlow / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12	Dec'11	Dec'10	Dec'09	Dec'08	Dec'07
Cash flows from operating activities:
Cash receipts from customers
248,393	186,519	176,594	172,310	148,954	132,406	114,993	113,205	97,688	94,503	93,568	82,250	72,533
Cash paid for inventory and prescriptions dispensed by retail network pharmacies
149,655	148,981	146,469	-	122,498	105,362	91,178	90,032	75,148	73,143	73,536	64,131	56,319
Insurance benefits paid
52,242	6,897	2,810	-	-	-	-	-	-	-	-	-	-
Cash paid for inventory and prescriptions dispensed by retail network pharmacies
149,655	148,981	146,469	140,312	-	-	-	-	-	-	-	-	-
Insurance benefits paid
52,242	6,897	2,810	2,199	-	-	-	-	-	-	-	-	-
Cash paid to other suppliers and employees
28,932	17,234	15,348	15,478	14,035	15,344	14,295	13,643	13,635	13,778	13,121	11,832	10,769
Interest received
955	644	21	20	21	15	8	4	4	4	5	20	34
Interest paid
2,954	2,803	1,072	1,140	629	647	534	581	647	583	542	574	468
Income taxes paid
2,717	2,383	2,909	3,060	3,274	2,931	3,211	2,282	2,406	2,224	2,339	1,786	1,781
Net cash provided by operating activities
12,848	8,865	8,007	10,141	8,539	8,137	5,783	6,671	5,856	4,779	4,035	3,947	3,230
Cash flows from investing activities:
Proceeds from sales and maturities of investments
7,049	817	61	91	243	161	136	0	60	1	-	28	0
Purchases of investments
7,534	692	137	80	-	-	-	-	-	-	-	-	-
Purchases of property and equipment
2,457	2,037	1,918	2,224	2,367	2,136	1,984	2,030	1,872	2,005	2,548	2,180	1,805
Proceeds from sale-leaseback transactions
5	0	265	230	411	515	600	529	592	507	1,562	204	601
Acquisitions (net of cash acquired)
444	42,226	1,181	524	11,475	2,439	415	378	1,441	177	101	2,651	1,984
Proceeds from sale of subsidiary and other assets
0	832	0	0	-	-	-	7	250	-	-	19	106
Purchase of available-for-sale investments
-	-	-	-	267	157	226	0	3	-	5	-	0
Other
-42	-21	-33	-37	35	11	54	23	4	34	23	-	-
Net cash used in investing activities
-3,339	-43,285	-2,877	-2,470	-13,420	-4,045	-1,835	-1,849	-2,410	-1,640	-1,069	-4,580	-3,082
Cash flows from financing activities:
Net borrowings of short-term debt
-720	-556	-598	1,874	-685	685	-690	-60	450	-15	-2,729	959	242
Proceeds from issuance of long-term debt
3,736	44,343	0	3,455	14,805	1,483	3,964	1,239	1,463	991	2,800	350	6,000
Repayment of debt assumed in acquisition
-	-	-	-	-	-	-	-	-	-	-	353	0
Repayments of long-term debt
8,336	5,522	0	5,943	2,902	3,100	0	1,718	2,122	2,103	653	2	822
Purchase of noncontrolling interest in subsidiary
-	-	-	-39	-	0	-	26	0	-	-	-	-
Payment of contingent consideration
-	-	-	26	58	0	0	-	-	-	-	-	-
Payments for (Proceeds from) Derivative Instrument, Financing Activities
25	-446	0	0	-	-	-	-	19	5	3	-	0
Repurchase of common stock
0	0	4,361	4,461	5,001	4,001	3,976	4,330	3,001	1,500	2,477	23	5,370
Dividends paid
2,603	2,038	2,049	1,840	1,576	1,288	1,097	829	674	479	439	383	323
Proceeds from exercise of stock options
210	242	329	296	362	421	500	836	431	285	250	328	553
Payments for taxes related to net share settlement of equity awards
112	97	71	72	63	106	62	28	21	28	19	53	98
Other
0	1	-1	-5	-3	0	0	-	-9	-	-	-	-
Net cash provided by financing activities
-7,850	36,819	-6,751	-6,761	4,879	-5,694	-1,237	-4,860	-3,460	-2,798	-3,232	929	378
Effect of exchange rate changes on cash, cash equivalents and restricted cash
0	-4	1	2	-20	-6	3	0	0	-	-	-	-
Net increase in cash, cash equivalents and restricted cash
1,659	2,395	-1,620	912	-22	-1,608	2,714	-38	-14	341	-266	296	526
Reconciliation of net income to net cash provided by operating activities:
Reconciliation of net income (loss) to net cash provided by operating activities:
Net income
6,631	-596	6,623	5,319	5,239	4,644	4,592	3,862	3,458	3,424	3,696	3,212	2,637
Adjustments required to reconcile net income to net cash provided by operating activities:
Adjustments required to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
4,371	2,718	2,479	2,475	2,092	1,931	1,870	1,753	1,568	1,469	1,389	1,274	1,095
Goodwill impairments
0	6,149	181	0	-	-	-	-	-	-	-	-	-
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement
0	0	-187	0	-	-	-	-	-	-	-	-	-
Stock-based compensation
453	280	234	222	230	165	141	132	135	150	165	92	78
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax
205	86	0	-	-	-	-	-	-	-	-	-	-
Loss on early extinguishment of debt
-79	0	0	-643	0	-521	0	-348	0	-	-	-	-
Deferred income taxes and other noncash items
-	-	-	-	-	-58	-86	-111	144	30	48	-3	39
Change in operating assets and liabilities, net of effects from acquisitions:
Deferred income taxes
-654	87	-1,334	18	252	-	-	-	-	-	-	-	-
Other noncash items
-264	-253	-53	-135	14	-	-	-	-	-	-	-	-
Gain on sale of subsidiary
-	-	-	-	-	-	-	-	53	-	-	-	-
Change in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable, net
2,158	1,139	941	243	1,594	737	2,210	387	748	-532	86	291	-280
Inventories
1,075	1,153	514	742	1,141	770	-12	853	-586	352	1,199	488	448
Other current assets
-	-	-	8	-355	383	-105	-3	420	4	-48	-12	59
Other assets
614	3	338	-	-2	-9	135	99	49	210	2	-19	26
Accounts payable and pharmacy claims and discounts payable
3,550	2,329	1,710	2,189	2,834	1,742	1,024	1,147	1,128	-40	4	-64	-181
Health care costs payable and other insurance liabilities
320	-311	0	-19	-	-	-	-	-	-	-	-	-
Accrued expenses
-	-	-	-	892	1,060	471	766	105	-176	-66	183	-168
Other liabilities
1,476	165	-333	152	-104	13	-1	110	2	-44	38	1	-17